Matthew A Warner1, Ryan D Frank2, Timothy J Weister3, Mark M Smith4, James R Stubbs5, Daryl J Kor1. 1. Division of Critical Care Medicine, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota. 2. Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota. 3. Anesthesia Clinical Research Unit, Mayo Clinic, Rochester, Minnesota. 4. Division of Cardiothoracic Anesthesia, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota. 5. Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Abstract
BACKGROUND: Intraoperative plasma transfusion is common, yet little is known regarding its effects on perioperative coagulation tests or clinical outcomes. STUDY DESIGN AND METHODS: This is a retrospective cohort study of adults receiving intraoperative plasma transfusion at a single center from 2011 to 2015. Relationships between plasma transfusion volume, changes in coagulation test values, and clinical outcomes, including a primary outcome of early postoperative red blood cell (RBC) transfusion, were assessed with multivariable regression analyses. Secondary outcomes included hospital mortality, intensive care unit (ICU)- and hospital-free days, intraoperative RBC transfusions, and estimated blood loss. RESULTS: A total of 3393 unique patients were included, with median (IQR) transfusion of 2 (2-4) units. In multivariable analyses, higher plasma volumes were associated with worse outcomes, with each 1 mL/kg increase associated with increased odds for postoperative (1.02 [1.01-1.03], p < 0.001) and intraoperative RBCs (1.17 [1.16-1.19], p < 0.001) and fewer ICU- and hospital-free days (mean difference [95% CI], -0.08 [-0.12 to -0.05], p < 0.001; and -0.09 [-0.13 to -0.06], p < 0.001, respectively). Greater decreases in international normalized ratio (INR) following plasma transfusion were associated with decreased odds of postoperative RBCs (0.35 [0.25-0.47], p < 0.001), decreased mortality (0.50 [0.31-0.83], p = 0.007), and increased mean ICU- (1.31 [0.41-2.21], p = 0.004) and hospital-free days (1.15 [0.19-2.10], p = 0.018). CONCLUSION: In patients receiving intraoperative plasma transfusion, higher transfusion volumes were associated with inferior clinical outcomes; however, greater improvements in INR were associated with improved outcomes. Future prospective studies are necessary to better define these relationships and to explore plasma transfusion triggers beyond the limitations of INR.
BACKGROUND: Intraoperative plasma transfusion is common, yet little is known regarding its effects on perioperative coagulation tests or clinical outcomes. STUDY DESIGN AND METHODS: This is a retrospective cohort study of adults receiving intraoperative plasma transfusion at a single center from 2011 to 2015. Relationships between plasma transfusion volume, changes in coagulation test values, and clinical outcomes, including a primary outcome of early postoperative red blood cell (RBC) transfusion, were assessed with multivariable regression analyses. Secondary outcomes included hospital mortality, intensive care unit (ICU)- and hospital-free days, intraoperative RBC transfusions, and estimated blood loss. RESULTS: A total of 3393 unique patients were included, with median (IQR) transfusion of 2 (2-4) units. In multivariable analyses, higher plasma volumes were associated with worse outcomes, with each 1 mL/kg increase associated with increased odds for postoperative (1.02 [1.01-1.03], p < 0.001) and intraoperative RBCs (1.17 [1.16-1.19], p < 0.001) and fewer ICU- and hospital-free days (mean difference [95% CI], -0.08 [-0.12 to -0.05], p < 0.001; and -0.09 [-0.13 to -0.06], p < 0.001, respectively). Greater decreases in international normalized ratio (INR) following plasma transfusion were associated with decreased odds of postoperative RBCs (0.35 [0.25-0.47], p < 0.001), decreased mortality (0.50 [0.31-0.83], p = 0.007), and increased mean ICU- (1.31 [0.41-2.21], p = 0.004) and hospital-free days (1.15 [0.19-2.10], p = 0.018). CONCLUSION: In patients receiving intraoperative plasma transfusion, higher transfusion volumes were associated with inferior clinical outcomes; however, greater improvements in INR were associated with improved outcomes. Future prospective studies are necessary to better define these relationships and to explore plasma transfusion triggers beyond the limitations of INR.
Authors: Steven M Frank; Will J Savage; Jim A Rothschild; Richard J Rivers; Paul M Ness; Sharon L Paul; John A Ulatowski Journal: Anesthesiology Date: 2012-07 Impact factor: 7.892
Authors: Matthew A Warner; David A Woodrum; Andrew C Hanson; Darrell R Schroeder; Gregory A Wilson; Daryl J Kor Journal: Mayo Clin Proc Date: 2016-08 Impact factor: 7.616
Authors: Bryce R H Robinson; Mitchell J Cohen; John B Holcomb; Timothy A Pritts; Dina Gomaa; Erin E Fox; Richard D Branson; Rachael A Callcut; Bryan A Cotton; Martin A Schreiber; Karen J Brasel; Jean-Francois Pittet; Kenji Inaba; Jeffery D Kerby; Thomas M Scalea; Charlie E Wade; Eileen M Bulger Journal: Shock Date: 2018-09 Impact factor: 3.454
Authors: David E Meyer; Jacob W Reynolds; Rhonda Hobbs; Yu Bai; Beth Hartwell; Matthew J Pommerening; Erin E Fox; Charles E Wade; John B Holcomb; Bryan A Cotton Journal: Anesth Analg Date: 2018-08 Impact factor: 5.108
Authors: Mark M Smith; Daryl J Kor; Ryan D Frank; Timothy J Weister; Joseph A Dearani; Matthew A Warner Journal: J Cardiothorac Vasc Anesth Date: 2020-01-07 Impact factor: 2.628